Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,211,769
in 7 filings, $50K under 10b5-1 plans

Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 46 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-01-20 Benaim Ely Chief Medical Officer Grant or award · Restricted Stock Units +95,000 95,000
2017-01-20 Nolan Lisa Chief Business Officer Grant or award · Stock Option (right to buy) +315,000 315,000
2017-01-20 Nolan Lisa Chief Business Officer Grant or award · Restricted Stock Units +65,000 65,000
2017-01-20 Ahn Chang Ho Director Grant or award · Stock Option (right to buy) +330,000 330,000
2017-01-20 Ahn Chang Ho Director Grant or award · Restricted Stock Units +70,000 70,000
2016-07-06 Nolan Lisa Chief Business Officer Grant or award · Stock Option (right to buy) +1,200,000 1,200,000
2016-06-09 Rodgers Richard J Director Grant or award · Stock Option (right to buy) +225,000 225,000
2016-06-09 CARTHY MARK Director Grant or award · Stock Option (right to buy) +225,000 225,000
2016-06-09 Brandt Peter C. Director Grant or award · Stock Option (right to buy) +225,000 225,000
2016-06-09 Beever Charles Director Grant or award · Stock Option (right to buy) +225,000 225,000
2016-06-09 Cheong Kwang Soo Director Grant or award · Stock Option (right to buy) +225,000 225,000
2016-03-18 Suzdak Peter David Chief Executive Officer Grant or award +60,000 $0.32 $19K 60,000
2016-01-28 Benaim Ely Chief Medical Officer Grant or award · Stock Option (right to buy) +98,734 98,734
2016-01-28 Benaim Ely Chief Medical Officer Grant or award · Stock Option (right to buy) +500,000 500,000
2016-01-28 Jeong Tae Heum Chief Financial Officer Grant or award · Stock Option (right to buy) +98,853 98,853
2016-01-28 Jeong Tae Heum Chief Financial Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2016-01-28 Suzdak Peter David Chief Executive Officer Grant or award · Stock Option (right to buy) +411,689 411,689
2016-01-28 Suzdak Peter David Chief Executive Officer Grant or award · Stock Option (right to buy) +1,000,000 1,000,000
2016-01-28 Ahn Chang Ho Director Grant or award · Stock Option (right to buy) +214,461 214,461
2016-01-28 Ahn Chang Ho Director Grant or award · Stock Option (right to buy) +200,000 200,000

Page 17 of 22 · 437 trades